3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Recruiting
2
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Pancreatic Neoplasms
26
Carcinoma, Non-Small-Cell Lung
14
Breast Neoplasms
14
Neoplasm Metastasis
7
Triple Negative Breast Neoplasms
5
Squamous Cell Carcinoma of Head and Neck
4
Parkinson Disease 4, Autosomal Dominant Lewy Body
3
Neoplasms
3
Stomach Neoplasms
2
Ovarian Neoplasms
2
Metastatic Pancreatic Ductal Adenocarcinoma
2
Lung Neoplasms
2
Inflammatory Breast Neoplasms
2
Uveal Melanoma
1
Uterine Cervical Neoplasms
1
Unresectable Biliary Tract Cancer
1
Thyroid Neoplasms
1
Thyroid Carcinoma, Anaplastic
1
Thromboembolism
1
TNBC
1
Sarcoma
1
Peritoneal Neoplasms
1
Oropharyngeal Neoplasms
1
Non-small Cell Lung Cancer Metastatic
1
Mouth Neoplasms
1
Locally Advanced or Metastatic Solid Tumours
1
Locally Advanced Unresectable Pancreatic Cancer Treated With Chemoradiotherapy
1
Lip Neoplasms
1
Laryngeal Neoplasms
1
Head and Neck Neoplasms
1
Interventions
pembrolizumab
15
Paclitaxel
15
Carboplatin
13
Specimen Handling
6
Biopsy
6
durvalumab
5
Magnetic Resonance Spectroscopy
5
dostarlimab
4
Taxes
4
Surveys and Questionnaires
4
Observation
4
Letrozole
4
Everolimus
4
Cisplatin
4
olaparib
3
lenvatinib
3
ceralasertib
3
Doxorubicin
3
sacituzumab govitecan
2
pertuzumab
2
copanlisib
2
cabozantinib
2
atezolizumab
2
abemaciclib
2
Trastuzumab
2
Robotic Surgical Procedures
2
Pemetrexed
2
Nivolumab
2
Metformin
2
Megestrol Acetate
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Active not recruiting
×
Endometrial Neoplasms
×
130-nm albumin-bound paclitaxel
×
Clear all
NCT06132958
2026-04-03
TroFuse-005
Merck Sharp & Dohme LLC
Phase 3
Active not recruiting
710 enrolled